Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations

Pre-exposure prophylaxis (PrEP) with oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) prevented HIV acquisition among men and women in several trials and is broadly recommended. In the VOICE and FEM-PrEP trials, however, TDF/FTC-based PrEP did not prevent HIV acquisition among women in e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Koss, Catherine A., Bacchetti, Peter, Hillier, Sharon L., Livant, Edward, Horng, Howard, Mgodi, Nyaradzo, Mirembe, Brenda G., Gomez Feliciano, Kailazarid, Horn, Stephanie, Liu, Albert Y., Glidden, David V., Grant, Robert M., Benet, Leslie Z., Louie, Alexander, van der Straten, Ariane, Chirenje, Z. Mike, Marrazzo, Jeanne M., Gandhi, Monica
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
PrEP
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564054/
https://ncbi.nlm.nih.gov/pubmed/28253024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0202
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados